MUSK and myasthenia gravis: In the development of MuSK MG, high-affinity binding of MuSK antibodies may furthermore be extra critical, as functional monovalent (germlined) monoclonal MuSK antibodies lost significant binding capacity and in vitro pathogenicity (23).